Bristol-Myers Squibb
BMY
#165
Rank
HK$947.72 B
Marketcap
HK$465.38
Share price
-0.57%
Change (1 day)
2.40%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.28. In 2024 the company made an earnings per share (EPS) of -HK$34.65 a decrease over its 2023 EPS that were of HK$30.41.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-166.82%
2024-HK$34.65-213.92%
2023HK$30.4130.2%
2022HK$23.36-6.04%
2021HK$24.86-179.29%
2020-HK$31.35-281.37%
2019HK$17.29-27.21%
2018HK$23.75
2016HK$20.93175.26%
2015HK$7.60-19.83%
2014HK$9.48-22.44%
2013HK$12.2334.48%
2012HK$9.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.30 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.69 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.66-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.75-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.44 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.33 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.19-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$86.15 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.94 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK